Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression
Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression have?
Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression has 37 citations in the OpenAlex counts ScholarIQ stores.
When was Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression published?
Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression has 2023 year in the ScholarIQ index.
What is the open-access status of Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression?
Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression has hybrid oa status in the ScholarIQ index.
What is the DOI of Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression?
The DOI for Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression is on the source record.
What is the PMID of Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression?
The PMID for Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression is on the source record.
What is the OpenAlex record for Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression?
The OpenAlex for Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression is on the source record.